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ABSTRACT
As the need to minimize medication errors drives many medical facilities to come up with robust
solutions to the most common error that affects patient’s safety, these hospitals would be wise to
put a concerted effort into finding methodologies that can facilitate an optimized medical
distribution system. If the hospitals’ upper management is looking for an optimization method
that is an ideal fit, it is just as important that the right tool be selected for the application at hand.
In the present work, we propose the application of Axiomatic Design (AD), which is a process
that focuses on the generation and selection of functional requirements to meet the customer
needs for product and/or process design.
The appeal of the axiomatic approach is to provide both a formal design process and a set of
technical coefficients for meeting the customer’s needs. Thus, AD offers a strategy for the
effective integration of people, design methods, design tools and design data. Therefore, we
propose the AD methodology to medical applications with the main objective of allowing nurses
the opportunity to provide cost effective delivery of medications to inpatients, thereby improving
quality patient care. The AD methodology will be implemented through the use of focused
stores, where medications can be readily stored and can be conveniently located near patients, as
well as a mobile apparatus that can also store medications and is commonly used by hospitals,
the medication cart. Moreover, a robust methodology called the focused store methodology will
be introduced and developed for both the uncapacitated and capacitated case studies, which will
set up an appropriate AD framework and design problem for a medication distribution case
study.

Date of submission of thesis to committee: May 2013
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CHAPTER I
1.0 INTRODUCTION
In a health care professional’s quest to provide continuous quality patient care, it is imperative
that hospital management remains vigilant to find ways to pursue this commitment. One area
that has been under constant scrutiny in the medical profession is the occurrence of medication
errors. According to the National Coordination Council for Medication Error Reporting and

	
  

Prevention (2012), a medication error is defined as… any preventable event that may cause or
lead to inappropriate medication or patient harm while the medication is in the control of the
health care professional, patient or consumer…[21, 22]. Medication errors have been identified
as the most common type of error affecting the safety of patients and the most common single
preventable cause of adverse effects [22]. The National Coordination Council for Medication
Error Reporting and Prevention (2012) reported that an estimated 98,000 die every year from
medical errors in U.S. hospitals and a significant number of those deaths are associated with
medication errors [21]. Medication errors can occur at all stages of the medication process.
The four major types of medication errors in hospitalized are prescription errors (e.g. a wrong
drug, dose or form), transcription and/or interpretation errors (e.g. misinterpretation of
abbreviations, handwritten prescriptions or spoken prescriptions), preparation and dispensing
errors with correct prescription (e.g. errors in dispensing, calculation errors) and administration
errors (e.g. a wrong dose or infusion rate, a wrong administration time, omission of dose or
additional dose, incorrect handling of drugs during administration). Most of the medication
errors occur at the administration stage (53% median, range: 9-90.7%) [21]. For the present
thesis, the focus will be on finding ways to minimize drug distribution system errors.
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There are several factors that contribute to drug distribution system errors. Brady et al (2009),
highlighted contributing factors to medication errors, including information overload, lack of
clinical decision supports with general inadequacy in the ‘checks and balances’ inherent in any
drug administration process. Medication errors are also more prevalent with inappropriate
reliance on manual documentation or information systems that do not communicate with each
other. Omission errors due to the availability of non-stock drugs and through difficulty in
locating stock drugs prescribed generically but supplied in brand name packaging are also a
possibility. Incorrect or delayed transcriptions are another possible cause of medication errors.
Different drug administration systems are also associated with higher rates of medication errors.
New technologies such as computer-order entry systems, computerized medical records and barcoded enabled systems have the potential for nurses to make medication errors without the
proper supervision and guidance on how to use these products properly [22].
For the present thesis, a methodology will be presented to improve the medication distribution
process, with specific attention on the administering of medications by nurses, beginning at the
nurse’s station and ending at the patient area(s).
Engineering principles and tools will be utilized to assist in this effort. Engineering tools such as
simulation modeling could play a vital role by allowing engineers to study the behavior of this
medication distribution system. An invaluable advantage of simulation modeling is that it helps
designers and engineers to avoid repeated attempts to build multiple prototypes when analyzing
the design of new or existing complex systems. Simulation modeling has several inherent
principles that the engineer must be attentive to:
•

Model conceptualization requires system knowledge, engineering judgment and model
building tools
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•

A good modeler requires abilities and they are developed through practice

•

Modeling process is evolutionary

•

Problem statement is the primary controlling element for problem solving

For this reason, we propose the application of the Axiomatic Design (AD) methodology. The
AD methodology was developed by Dr. Nam Pyo Suh, a MIT professor who first proposed this
theory in the 1970’s. He defines it as a process that focuses on the generation and the selection
of functional requirements to meet the customer needs for product and/or process design [1]. He
also said that this concept could become an invaluable tool to many businesses because he
believes that it “helps to overcome the shortcomings of the product design and the product
development process that is based on a recursive ‘design/build/test’ cycle, which requires
continuing modifications and changes as design flaws are discovered through testing” [2].
The appeal of the axiomatic approach is to provide both a formal design process and a set of
technical coefficients for meeting the customer’s needs. Thus, AD offers a strategy for the
effective integration of people, design methods, design tools and design data [9].
In the present thesis, several key AD elements will be reviewed, such as:
1. Introduction to the key concepts of axiomatic design theory
2. Robustness of design by examining designs that involve concerns between the customer’s
needs and the definition of the functional requirements (FRs), and,
3. Principles and their implications for design
For an effective medical distribution system, there are several elements that must all be linked
together as an ongoing process. This includes a robust supply chain process, strong leadership in
inventory management, a multi-faceted purchasing process, and a prompt delivery system in
place to provide the medications to the patients as needed. In addition to these components,
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knowledgeable vendors that can deliver the medications on time, expert hospital management,
who ensures the proper distribution of medications to the right nursing stations and an
experienced nursing manager and nursing staff that promptly delivers the medications to the
patients on a timely basis.
In the present thesis, we propose applying the AD methodology to a medical distribution system
with the main objective of allowing nurses the opportunity to provide cost effective delivery of
medications to inpatients, thereby improving quality patient care. Therefore, in the present
approach, the primary objectives in using the Axiomatic Design methodology for the medication
distribution design analysis are to:
1. Maximize the amount of patients that have a single common medication, and,
2. Compare the results of the uncapacitated vs. the capacitated case for the medication
distribution problem
The first objective will be achieved through the use of focused stores, where medications can be
readily stored and can be conveniently located near patients, as well as a mobile apparatus that
can also store medications and is commonly used by hospitals, the medication cart.

Figure 1-1: Pictures of Medication Carts [4]
4

The medication cart is made by a number of companies such as Stanley Inner Space, Medline
and Rubbermaid. Its ease of mobility to be positioned in areas of the nursing ward that the
nurses deem appropriate allows them to continue to provide quality patient care. Most
importantly, it gives the hospital staff the means to provide medications to inpatients in a timely
fashion.
The first objective will be addressed by seeking opportunities to find the greatest number of
patients that have a single common medication. This concept is called the commonality factor,
which will be described in more detail in Chapter IV.
For the second objective, we will examine both the uncapacitated and capacitated scenarios for
the medication distribution case study presented in Chapter IV. The uncapacitated case is when
there are no restrictions on the amount of product that can be stocked and that is available. The
capacitated case is when there are restrictions placed on the amount of product that can be stored
and is available. Traditional rewarehousing/techniques of material allocation and additional
investment for processing are not considered in this case. On the other hand, the capacitated case
is when there are limitations as to the capacity or space that can store medications for the
patients. This is mainly due to the lack of resources that are available to stock the products.

5

CHAPTER II
2.0 LITERATURE REVIEW
This chapter is a review of recent and applicable literature related to the AD methodology and
the application of this concept to provide a good delivery process of the medications and
information about the health condition of the patients. A broad overview will be provided on the
supply chain management of delivering the medications to the patients in a timely fashion.
Emphasis will be directed to the AD concepts that can be integrated into this logistical operation.
2.1 Axiomatic Design Framework
AD has been applied to a variety of products, systems, organizations and processes such as
machines processes, space systems, software organizations and materials. Moreover,
organizations have been designed using AD to improve their efficiency by removing unnecessary
and sometimes undesirable human barriers and interactions [2].
The AD world is made up of four domains: (1) Customer Domain, (2) Functional Domain, (3)
Physical Domain and (4) Process Domain.
The customer domain should be characterized by the customer attributes (CAs) that the customer
desires in a product, process, system, organization or materials. In the functional domain,
customer needs are satisfied in terms of functional requirements (FRs) [2, 15, 16].
To satisfy the specified FRs, decision parameters (DPs) are conceived in the physical domain
Finally, to produce the product specified in terms of DPs, a process is developed that is
characterized by process variables (PVs) in the process domain. Many different fields including
manufacturing systems, software, hardware, materials, and organizations can be described in
terms of these four design domains [2, 5, 16].
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Suh (1998), incorporated the AD theory into the theory of systems by his development of the
FRs, DPs and PVs. Just like the AD theory, he believed that this systems theory had many
applications in different kinds of systems, including machines, large systems, software systems,
organizations, and systems consisting of a combination of hardware and software [16].
Moreover, Engelhardt (2000), merged the concepts of the FRs, DPs and PVs in his proposed
problem solving approach for existing designs in conjunction with seven quality control tools,
noise factor analysis and design experiments in order to complete a thorough investigation of
possible problems within the design to form an approach for quality improvements and problem
solving [17].
Kremer et al (2012), also incorporated these same concepts with the Theory of inventive
problem solving technique (TRIZ) and optimization in its effort to seek an optimal locomotive
ballast arrangement design system [6].
Once the perceived customer needs are identified and defined (i.e. the attributes the customer is
looking for in a product) in the customer domain, these needs must be translated into FRs in the
functional domain. This must be done within a ‘solution-neutral environment’. This means that
the FRs must be defined without ever thinking about something that has already been designed
or what the design solution should be.
Once the FRs are chosen, they must be defined into the physical domain through the design
parameters (DPs) that can satisfy the FRs. The mapping process is typically a one-to-many
process, that is, for a given FR, there can be many possible DPs. The right DP must be chosen
by making sure that other FRs are not affected by the chosen DP and that the FR can be satisfied
within its design range. Figure 2-2 illustrates this domain structure [2]:
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Mapping

Mapping

{CAs}

{FRs}

Customer
domain

Functional
domain

Mapping

{DPs}

{PVs}

Physical
domain

Process
domain

Figure 2-1: Four domains of the design world [2]
For defining a design in terms of a mapping process, this is illustrated in Figure 2-2. The domain
on the left represents what we want to achieve, relative to the domain on the right, which
represents the design solution, that is, how we propose to satisfy the requirements specified in
the left domain [2, 5].

How we
want
to achieve
it

What we
want
to achieve

Figure 2-2: Definition of Major Objectives of Axiomatic Design [2]
Gutierrez and Crispin (2005), used the concepts presented in Figure 2.2 when analyzing the
scheduling practices of a preprinting laminated tab divider manufacturer. The company’s desire
to have a quick response to customer demand and inquiry rapidly and efficiently lends to the
‘What we want to achieve’ phase since compliance with customer demands is vital for the
organization to retain and increase its market share. To conform with the ‘How we want to
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achieve it’ phase, this company relies on its ability to perform scheduling operating practices in
both the Made-To-Order (MTO) and Make-To-Stock (MTS) environments.
These production-scheduling decisions achieve two major objectives: (1) full resource
utilization and, (2) the quick response to product priorities based on product demand
requirements. There are several phases in this decision-making process to achieve an optimal
scheduling environment. The first phase is the rough-cut capacity assignment phase where a
global capacity analysis based on current production schedule and new orders based on due dates
and priorities are performed. The next step is a local capacity assignment phase where a
relationship matrix is developed for those items that are on the production/customer order
schedule and required in the upcoming week and/or current week. Then a clustering analysis for
initial product/capacity allocations is conducted. This is where a hierarchical clustering
algorithm is utilized to construct a logical number of clusters given the computationally difficult
class of NP-complete problems. Finally, candidate items for the proposed clusters from the nonhierarchical clustering analysis are then selected on the order scheduling system using the order
assignment factors such as priority, capacity required, and size of the demand transaction. Pairwise interchanges for the same sized clusters and adjacent clusters are performed to improve
assignments by trading off machine/cells and due dates. For the most efficient arrangement, the
actual assignments are performed and the number of required scheduling times for each order are
generated [11].
2.2 Axioms in the Axiomatic Design
The basic postulate of an AD theory is that there are fundamental axioms that define acceptable
designs. Axioms have played a major role in developing mathematics, natural sciences and
engineering, for example, Newton’s laws of mechanics, Euclid's geometry, and the laws of
9

thermodynamics. These axioms also help to eliminate the possibility of making mistakes when
products – both hardware and software – are developed [2].
The first axiom is called the Independence Axiom. To satisfy the conditions of this axiom, the
independence of FRs must always be maintained [2, 5, 6, 7, 13]. It also implies that when there
are several FRs, the design must be such that the FR can be satisfied without affecting any of the
other as FRs [2]. The second axiom is known as the Information Axiom, which states that
among those designs that satisfy the Independence Axiom, the design with the highest
probability of functional success will be the best design [2, 5, 6, 7, 13].
2.3 The First Axiom: The Independence Axiom and the Design Process
The Independence Axiom states that the independence of the FRs must always be maintained
[23]. The relationship between FRs is decided by the choice of DPs. It should be noted that FRs
are independent from each other by definition. Therefore, we have to choose a correct set of DPs
to be able to satisfy the FRs and maintain their independence [2].
Once the FRs have been established, the next step is to conceptualize the design solutions. This
is a mapping process from ‘what’ in the functional domain to ‘how’ in the physical domain.
During this process, we must consider the different ways of fulfilling each of the FRs by
identifying plausible DPs. Sometimes it is convenient to consider a specific DP to satisfy a
specific FR, repeating the process until the design is completed.
When there are many FRs, the design task can become difficult since the Independence Axiom
may be violated. Measures must be taken to ensure that these difficulties are addressed early in
the process [2, 6, 7].
To create an engineered system that is acceptable, the FRs and constraints related to that could
arise must be identified and designed for from the very beginning of the design process. To
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satisfy these and other FRs of the system, DPs and PVs must be chosen. Any physical
embodiment of products and systems is acceptable as long as the FRs are satisfied with any
given set of constraints. Unless FRs are correctly defined at the beginning of the design process,
it becomes difficult to incorporate human factors when the design is completed. It is equally
difficult to modify an existing system to issues that may arise [2].
The design equation relating these FRs and DPs together is [9, 13]:
𝐹𝑅 = 𝐴 {𝐷𝑃}

(2.1)

where [A] is called the Design Matrix that relates FRs to DPs and characterizes the product
design. For a design that has three FRs and three DPs, the design matrix is the following:
𝐴11 𝐴12 𝐴13
𝐴 = 𝐴21 𝐴22 𝐴23
𝐴31 𝐴32 𝐴33

(2.2)

Equation (1) is a design equation for the design of a product; in differential form it is written as:
d𝐹𝑅 = 𝐴 {𝑑𝐷𝑃}
where the elements of the design matrix are given by:
𝐴𝑖𝑗 =   

𝜕𝐹𝑅𝑖
𝜕𝐷𝑃𝑗

For a linear design, As are constants; for a nonlinear design, As are functions of the DPs. There
are two special cases of the design matrix:
(1) The diagonal matrix, where all Aij = 0 except for those where i = j.
𝐴11
0
0
𝐴 = 0
𝐴22
0
0
0
𝐴33
(2) The triangular matrix as shown below:

(2.3)

𝐴11
0
0
𝐴 = 𝐴21 𝐴22
0
𝐴31 𝐴32 𝐴33

(2.4)
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For the design of processes involving mapping from the {DP} vector in the physical domain to
the {PV} vector in the process domain, the design equation may be written as:
𝐷𝑃 = 𝐵 {𝑃𝑉}

(2.5)

where [B] is the design matrix that defines the characteristics of the process design and is similar
in form to [A].
Albano and Suh (1994), utilized many of the concepts previously discussed in his application of
AD in concurrent engineering. He felt that the DPs specified in the physical domain are
functional requirements that must be satisfied in the process domain. He also believed that the
zigzag mapping and decomposition activities must be coordinated across the functional, physical
and process domain. Finally, he mentioned that representing the product and process designs in
terms of matrix mapping supports a number of operations that can increase the efficiency of
integrating the contributions of multiple design disciplines [9].
To satisfy the independence axiom, the design matrix must be either diagonal or triangular. If
the design matrix [A] is diagonal, then each of the FRs can be satisfied independently by its
respective DP. Such a design is called an uncoupled design. When the matrix is triangular, the
independence of FRs can be guaranteed if and only if the DPs are determined in a proper
sequence. Such a design is called a decoupled design. Any other form of the design matrix is
called a full matrix and results in a coupled design [2, 4, 15].
2.4 Corollaries and Theorems
Many corollaries and theorems have been derived. A few theorems will be stated here to show
the useful nature of these theorems in design.
Theorem 1 (Coupling due to insufficient number of DPs): When the number of DPs is less than
the number of FRs, either a coupled design results or the FRs cannot be satisfied.
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Theorem 2 (Decoupling of coupled design): When a design is coupled due to the greater
number of FRs and DPs, it may be decoupled by the addition of new DPs so as to make the
number of FRs and DPs equal to each other, if a subset of the design matrix containing n x n
elements constitutes a triangular matrix.
Theorem 3 (Redundant design): When there are more DPs than FRs, the design is either a
redundant design or a coupled design.
Theorem 4 (Ideal design): In an ideal design, the number of DPs is equal to the number of FRs,
and the FRs are always kept independent from each other.
When the design is a redundant design, which may be intentional or unintentional, it may be
systematically reduced to an uncoupled design or a decoupled design [2].
2.5 Decomposition, Zigzagging and Hierarchy
Figure 2-3 illustrates the decomposition of the FRs and DPs through zigzagging between the
functional and physical domains. We start out in the ‘what’ domain and go to the ‘how’ domain.
In the physical (how) domain we can conceptualize a design and determine a DP that will
correspond to the FR that must be satisfied. Once a DP is chosen, we zigzag to the functional
domain to create FR1 and FR2 at the next level that collectively satisfy the highest-level FR.
FR1 and FR2 are the FRs for the highest-level DP. Then we select DP1 and DP2 to satisfy FR1
and FR2, respectively. This process of decomposition is continued until all of the branches reach
the final state, where they do not need to be decomposed any further. The final state is indicated
by thick boxes, which are called ‘leaves’ [9, 16].
Turhan et al (2011), utilized the decomposition technique as part of a decision-making tool
incorporating supply chain balanced scorecard performance measured for supply chain
reengineering for a paint company [14].
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Yenisey (2007), merged the decomposition procedure in his approach to create a design process
in his quest to create quality E-commercial websites [19].
Ullah (2005), also incorporated the idea of decomposing the FRs and DPs in his axiomatic
design-like formulation using linguistic design formulations (LDFs) in order to develop an
effective method for determining the optimal design embodiments under the following
assumptions: (1) the design approach involves the axiomatic design theory, and (2) the designrelevant information refers to a designer’s intuition, expressible as qualitative computer
information, known as f-granular information [18].

Figure 2-3: Comparison of Traditional Functional Decomposition Model vs. Axiomatic
Decomposition “Zigzagging” in functional and physical domains to create FR and DP
hierarchies [2]
14

Figure 2–3 also illustrates a case with five abstraction levels. The top FR and DP are fairly
abstracted. The design details are developed as the design is decomposed [2, 6, 7, 14].
For each level of decomposition we must specify the design equation: (FR) = [A](DP). This is
to be sure that the right sign decision was made.
Suppose that the designer came up with the decoupled design represented by the following
design equation:
!"1
!"2

=   

𝑋
𝑋

0
𝑋

!"1
!"2

(2.6)

Since design details have not been developed at this stage of the design process, the triangular
matrix represents the design intent. All subsequent lower-level design decisions must be
consistent with this high-level design decision. At each level of decomposition, the design
decisions must be made consistent with all higher-level design decisions.
A designer must develop detailed designs that do not violate the original design intent. When he
finds that existing technologies cannot be used, new inventions and innovations must be created.
Whenever possible, we must model and analyze the proposed design. In some cases, the design
matrix, which is formulated in terms of X and 0, must be further developed by replacing the X’s
with the equations or numbers. We will then have a set of equations that relate FRs the DPs [2].
2.6 The Second Axiom: The Information Axiom
There may be many acceptable designs that satisfied the Independent Axiom. For a given set of
FRs, there may be many acceptable design solutions. The Information Axiom can be useful in
selecting the best among those designs. The Information Axiom provides the theoretical basis
for design optimization and robust design. It states that a design with the minimum information
content is the best design.
Information content Ii for a given FRi is defined in terms of the probability Pi of satisfying FRi.
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!

𝐼𝑖 =   log2 ! =    −  log2  𝑃𝑖

(2.7)

𝑖

The information content is expressed in bits of information. The logarithmic function is chosen
so that the information content will be additive, which is useful when many FRs must be
satisfied simultaneously.
In the general case of m FRs, the information content for the entire system Isys is:
𝐼𝑠𝑦𝑠 =    −  log2  𝑃(𝑚)

(2.8)

where P(m) is the joint probability that all m FRs are satisfied.
When all FRs are statistically independent as is the case for an uncoupled design,
!

𝑃

𝑚    =   

𝑃𝑖
!!!

then Isys may be expressed as:
Isys =

!
!!! 𝐼𝑖

=    −

!
!!! log2 𝑃𝑖

(2.9)

When all FRs are not statistically independent, as is the case for a decoupled design,
𝑃
where 𝑃𝑖

𝑗

𝑚    =   

!
!!! 𝑃𝑖

𝑗

for 𝑗 = 1, … , 𝑖 − 1

(2.10)

is the conditional probability of satisfying FRi given that all other relevant

(correlated) {FRj}j=1,…,i-1 are also satisfied. In this case, Isys may be expressed as:
Isys =

!
!!! log2 𝑃𝑖

𝑗

for 𝑗 = 1, … , 𝑖 − 1

(2.11)

The Information Axiom states that the design with the smallest I is the best design, since it
requires the least amount of information to achieve the design goals. When all probabilities are
equal to 1.0, the information content is zero, and, conversely, the information required is infinite
when one or more probabilities are equal to zero. That is, if the probability is small, we must
supply more information to satisfy the FRs [2, 13, 16].
Weng and Jenq (2012), incorporated many of the concepts concerning the information axiom to
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improve the design of machine tools and equipment used for agile manufacturing units as well as
contribute to the evaluation model in the decision-making process to maximize the evaluation
indices [7].
The FR must be satisfied within us the specified range, which we define as a design range, we
accept the design. The probability of success is governed by the intersection of the design range
defined by the designer to satisfy the FRs and the ability of the system to produce the product
within the specified range [2]. The probability of success can be computed by specifying the
design range for the FR and by determining the system range (DP range) that the proposed
design can provide to satisfy the FR. Figure 2-4 illustrates these two ranges. The vertical axis
represents the probability density and the horizontal axis represents either the FR or DP,
depending on the mapping domains involved; for product design, the horizontal axis is a FR and
for process design, it is a DP [2, 8].

Figure 2-4: Design range, system range, common range and system PDF for a FR [8]
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Clearly, those instances of the system range which contribute to the distribution shown in the
shaded area, A1, are acceptable designs (successes), while those that fall outside this range, in
area A2, are unacceptable (failures). Thus, the probability of success, P, in this case would be:
𝑃   =   𝐴1/(𝐴1   +   𝐴2)

(2.12)  

If the DPs are distributed uniformly over the system range (uniform distribution instead of
normal), then a simpler formula to use would be [8]:
𝑃𝑟𝑜𝑏𝑎𝑏𝑖𝑙𝑖𝑡𝑦  𝑜𝑓  𝑠𝑢𝑐𝑐𝑒𝑠𝑠   𝑃 =   

!"##"$  !"#$%
!"!#$%  !"#$%

(2.13)

To achieve a robust design, the system range should lie inside the design range, thus reducing the
information content to zero. This can be achieved if the variance of the system and the bias are
small. The bias can be eliminated if the design satisfies the Independence Axiom [2].
Celik et al (2009), utilized the ideas contained in the Information Axiom, in particular the
concepts associated with the design range, system range, common range and system probability
density function for a FR when he was developing a systematic evaluation model on docking
facilities of shipyards to provide a decision aid for technical ship managers and to perform this
responsibility in an efficient manner [10].
2.7 Axiomatic Design Process
Understanding the customers’ needs is paramount for successfully converting their suggestions
into a tangible concept that can be utilized to improve a product, organization, system or
material. Their recommendations are often stated in non-engineering terms (e.g. a stereo system
that sounds good). Also, several of the requirements may be implicit. It is the engineering
designer’s task to identify and adapt these requirements to somewhat more engineering specific
requirements (the Signal to Noise ratio of the stereo must exceed 100 decibels). Thus, the
customers’ needs are converted into a set of FRs that will be satisfied by the design. The actual
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design artifacts that satisfy each of the FRs lie in the design domain (a particular combination of
pre-amplifier and power amplifier that yield the required signal amplification) [8].
In the present study, the nurse manager would be the customer with the main objective of
“Ensure quality patient care by getting the medications to the patients on time.” Converting this
into an engineering statement would yield the following result, “Minimize the delivery costs of
medications to the patients.” This statement would be the problem definition.
Figure 2-5 provides a step-by-step process when developing an application of axiomatic design.
Following its path, the FRs, DPs and the PVs should be determined. The FRs are needed to
identify the customer requirements; the DPs are the means to satisfy the FRs and the PVs are the
manpower, tools or material handling to accommodate the DPs. At this point, the constraints
should be developed in order to determine the acceptable bounds for the case study. This
information should be combined and arranged in terms of the maximization and/or minimization
of the candidate DPs and PVs. Then, the main issue for each product will be decomposed into
basic-level problems [6]. There should be one FR to one DP (i.e. a coupled design will be
obtained). It is required that the parameter design matches the FR. It is mandatory to explain the
AD procedure for definition and design information that is necessary to match the FRs with the
parameter design and improve the satisfaction of the original need to the evaluation of the
information content.
Uang et al (2011), used this step-by-step approach in conjunction with the Theory of Inventive
Problem Solving (TRIZ) to establish a systematic product design model for a handheld Global
Positioning System (GPS) product. The model’s efficiency was analyzed and evaluated to
determine its effectiveness [20].
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Figure 2-5: Axiomatic Design Procedure [5]
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CHAPTER III
3.0 INTRODUCTION
Section 3.1 discusses several important concepts that are pertinent to the medication distribution
design problem. Section 3.1.1 starts this chapter with an introduction to multi-echelon inventory
systems, which lays the groundwork when performing a sensitivity analysis for different
parameters of an ideal medication distribution system. The focused store (i.e. storage media that
can store medications within the vicinity of patients) methodology proposed in Section 3.1.2 is
presented as a decision support tool and will serve as a tie-in between the theory of multi-echelon
inventory systems as well as the development of a mathematical model (in the next chapter) for
both an uncapacitated and capacitated medication distribution case study. It requires the
assumption of a planning horizon. In Section 3.2, the different medication stocking definitions
and processes are introduced in section 3.2.1 while in section 3.2.2 an axiomatic design
framework for the medication distribution problem is presented. Section 3.3 follows with
general costs concepts pertinent to the medication distribution problem.
3.1 Concepts
3.1.1 Multi-Echelon Inventory Systems
The multi-echelon inventory system is characterized by three administrative components: the
organizational structure, policies governing purchases and inventories, and dynamic operating
actions and decisions.
The echelons define the organizational structure where the inventory exists. The policies
governing purchases and inventories are the set of rules established for daily activity such as
levels of working process inventory, replenishments, vendor product supply, decentralized stores
inventory, and levels of reorder point.
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Dynamic operating actions and decisions refer to the production orders required to satisfy
customer demands as well as the multi-bin/medication order system signals required to adjust
inventory fluctuations at the focused stores based on the level of medication distribution activity.
Given the current level of activity at the vendor’s headquarters where the customer’s medication
orders are being loaded to the current weekly production master schedule without any time fence
considerations, it is assumed one-week time fence as a period of influence for decision-making
efforts. The organization of the multi-echelon inventory system is shown below:

Figure 3-1: Multi-Echelon Inventory System
Figure 3-1 consists of a source (i.e. the vendor warehouse) from where the medications
originated from could be transported to the nurse’s station. The nurse’s station is the primary
storage area for the medications and serves as the designated pickup point where the nurses can
transfer the medications to the medication cart. The nurse can use this medication cart to deliver
medications to the patients. There are n patient areas (n is the number of patients) where the
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patients are located (i.e. PA1, PA2, PA3,…, PAn), and n-1 focused stores (FS12, FS23,…, FS
(n-1) n) that can store the medications within the vicinity of the patients and the stationary
focused stores and can be resupplied as needed. In this particular setup, the patients can be
served by either the medication cart or FS12, which is placed between PA1 and PA2. Similarity,
the medication cart or FS23 serves PA2 and PA3 and FS (n-1) n is for PA (n-1) and PAn.
One of the most important points in this schematic is the emphasis on the paths that are
illustrated. The supply path (represented as the dark arrow

) is a supply chain route primarily

between the vendor warehouse and the nurse’s station. The lateral transshipments (displayed as
two dots joined by a line

) are replenishing events between each of the medication carts

where the nurses can conveniently resupply one stationary focused store from another focused
store. The service paths (depicted by the light arrow

) represent a trail where medications

can be given to patients individually. Again, these medications are taken directly from the
stationary focused store to the particular patient. Finally, the resupply paths (shown as the
dashed light arrow

) are restocking opportunities for hospital staff to deliver medications

from the medication cart to each of the stationary focused stores.
The methodology is designed to respond to demands placed on stocking points based on the
requirements at the finished goods level, subassembly level and the stocking points at different
points in time based on material consumption. It also includes the modeling of demand
processes for intermittent customer demand patterns. Demands depend on the needs at the
higher echelon levels, for different times, quantities, and priorities and can be routed to different
stocking points within the system.
The decision to stock a medication at the focused store depends on its commonality relative to
the storage locations. In this regard, the metric for measuring commonality is defined by the
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number of patients consuming the medication. The decision regarding where a medication may
be stocked in the focused stores is based on cost-tradeoffs. Thus, a shared focused store offers
the advantage of reduced safety stock due to risk pooling. However, this advantage may be
offset by additional handling costs.
Finally, Figure 3-1 sets the stage for several possible scenarios that would be investigated for the
medication distribution design problem:
1. Commonality factor (CF) = 1, (a fully centralized system, which tends to support the
uncapacitated case; medications would be located at the nurse’s station)
2. CF = 2, (depicting either a fully centralized system or a fully decentralized system)
3. CF = 3 and higher, (depicting a fully decentralized system which tends to support the
capacitated case; medications would be located in the focused stores at or near the
patient rooms)
Both the uncapacitated and capacitated case will be explained in further detail in Chapter IV.
3.1.2 Focused Stores Methodology
The proposed methodology is defined in five major phases of data analysis and is shown in
Figure 3-2. These major phases in simplified terms can be defined as:
Phase I:

Uncapacitated location

Phase II:

Uncapacitated allocation

Phase III:

Bin sizing (Medication order)

Phase IV:

Capacitated location

Phase V:

Slotting
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Figure 3-2: Major phases of Focused Store methodology
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Phase I provides the clustering analysis to group sets of medication-based commonality,
Duration of Stay (DOS), and medication-allocation timing. Phase II identifies the medication
allocation, which is amongst the medication clustering and between the central warehouse and
the focused stores. At this juncture, any conditions of cluster overloading and lateral
transshipments should be solved before proceeding to Phase III. Bin sizing/medication order
analysis should account for conditions such as volumetrics and service levels and is required to
identify “ideal” size and type of storage media. Under conditions of unfeasibility of sizing/order
parameters, the analysis requires that Phase II be performed again until sizing/order selected
parameters from Phase III becomes feasible. Phase IV determines the assignment of medications
to actual available storage media that reflect conditions of space, priorities, and facility and
warehousing costs. The decision to proceed to Phase V should be made only when it is feasible
to assign medication types. Otherwise, the analysis will require recalculation of Phase II and III.
Phase V defines medication types to specifications considering ergonomic conditions. Thus, it is
required that Phase IV be recalculated for re-allocation of space among ergonomic and nonergonomic medication distribution conditions.
The objective of Phase I is to define clusters of different medications that are associated based on
similarities of seven dimensions: Demand, volumetrics, commonality, Duration of Stay (DOS),
timing, carrying cost and unit cost. One major constraint that should be addressed is the
customer intermittent demand, where the vendor does not have control. Demands are not all
similar; they may be for different finished goods, different quantities, contain different priorities,
and have different backorders and shipment policies. The ability of modeling production
conditions is difficult and complex. Therefore, a proposed forecasting method is applied to
generate material production requirements at the component level, considering bill of materials
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and production routings to characterize the medication-patient area relationship. Another aspect
that is considered is the DOS, which refers to time buckets required for material consumption in
the patient area. Longer DOS corresponds to higher space requirements in the focused stores and
higher material handling requirements if the material is not located next to patient area. The
shorter or the average DOS represents lower requirements in terms of time buckets within the
production plan and lowering carrying cost for inventory cost. Timing is an important dimension
for medication clusterization given the inventory constraints of space and volume in the patient
areas. Unit cost of material is also considered during the clusterization analysis.
The material allocation among the medication carts and the focused stores is the objective of
Phase II. It is considered material allocation across different patient areas under conditions of
high commonality; there is more than one focused store that is needed to store the same
medications. Furthermore, it is required to analyze multi-echelon inventory systems at the
service levels, patient area usage and nursing ward layouts for material handling across the
patient areas. Conditions of transshipments among the same echelons for material commonality
and clustering overlapping are considered and revised between Phases I and II.
The conditions of lumpiness in the demand variation are considered at this point to validate the
operating conditions of the multi-bin sizing/medication order inventory system as a viable tool
for specific demand conditions. Push systems will be advised as a potential implementation tool
to control materials when this system is not valid under lumpiness conditions of demand.
The objective of Phase III is to determine the “ideal” bin/medication order storage media that is
necessary for the current production schedules for each stocking point. It is considered in the
analysis conditions of order interval, lead time, volumetrics, service level and shortage cost. To
validate the solution given in Phase III, the current storage conditions and storage media
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available are considered in Phase IV.
The assignment of medication type to the actual available storage media is the objective of Phase
IV. In this phase of the algorithm, it is defined as the cost model to incorporate cost information
of the nursing ward layout and replenishment. Moreover, it is incorporated information of space,
storage media available and priorities. Given that the current conditions of operating Phase III
are recalculated, if recalculation of the ideal storage media is also required, this is needed to
identify the required storage media for Phase IV.
The objective of Phase V is to define the medication distribution specifications given conditions
of weight and ergonomics. The purpose of this is to identify adequate conditions of material
storage and retrieval from the storage media located next to the patient areas. Given the
constraints of space, if the solution of Phase V requires recalculation, then Phase IV must also be
recalculated among ergonomic and non-ergonomic conditions.
3.2 Mathematical Modeling for Medication Distribution Design Problem: the case of finite
production rate
3.2.1 Medication stocking definitions and processes
Unit load is a term that is well known to persons involved with material handling, particularly
with warehouse activities. The most common example is an arrangement of cartons that is
stacked in layers and on a pallet. They would be moved from the vendor warehouse to the
nursing stations, which will serve as the primary storage area for the medications as well as the
pickup point for the medications to be distributed. The medications can also be stored either at
the nurse’s station or at the stationary focused stores.
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3.2.2 Axiomatic Design Framework for the Medicine Distribution System
The FR for this medication distribution system is defined as the minimization of the costs
associated with delivery of medications to inpatients. The constraint considered in this case is
the storage capacity of the medication cart. These needs are mapped onto the top-level FR with
the associated DP and then are decomposed into lower-level FRs and DPs as shown in the
following table:
Table 3-1: FRs with the Corresponding DPs for the Medicine Distribution System Case Study
Objective	
  
Functional	
  Requirements	
  
	
  FR1	
  Minimize	
  delivery	
  costs	
  of	
  medications	
  
to	
  patient	
  
FR1.1	
  Ready	
  access	
  to	
  all	
  medications	
  for	
  
each	
  nurse	
  
FR1.2	
  Restock	
  cart	
  or	
  FS	
  periodically	
  with	
  
medications	
  
FR1.3	
  Secure	
  cart/FS	
  to	
  prevent	
  theft	
  of	
  
medications	
  
FR1.4	
  Ready	
  access	
  to	
  medication	
  
information	
  to	
  each	
  nurse	
  

Solution	
  
Design	
  Parameters	
  
	
  Utilization	
  of	
  medication	
  cart	
  (cart)	
  and/or	
  
Focused	
  Stores	
  (FSs)	
  
Locate	
  cart	
  near	
  patients	
  and/or	
  FSs	
  in	
  vicinity	
  
of	
  patient	
  areas	
  
Nurse’s	
  station	
  and/or	
  FS	
  near	
  patient	
  rooms	
  
that	
  is	
  stocked	
  with	
  medications	
  
Unique	
  combination	
  code	
  for	
  each	
  nurse	
  
Computer	
  containing	
  medication	
  information	
  or	
  
patient	
  medication	
  cards	
  

If the independence axiom is applied to the table above, it should lead to the establishment of a
coupled design for this analysis. The application of the FRs and DPs shown in Table 3-1 should
lead to the identification of an input constraint that corresponds to this design. The information
axiom should be applied to allow further evaluation of the alternative design process.
Presuming a specific storage location in the proposed multi-echelon network, the next task is to
develop a quantitative model that can be used to determine the location/allocation for the
different medicine types, which will be described in the next chapter. This is given that the cart
will be frequently moved to different areas of the nurse’s ward that are within the vicinity of
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patient rooms. It is also expected that there is adequate space for medications in the cart or
focused store, which renders an uncapacitated location/allocation problem [5].
Customer Info
* products
* markets
* Performance
Metrics

Total Modification Strategies
Performance Requirements
Medication
Medication
Distribution
Distribution
Analysis
Supply Chain Design

Medication Cart
System Design

Demand

Medication
Partner Info
*capacities
*channels
*Performance
Metrics

Performance
Metrics

Four Domains of the Designs
Uncap. Location/
Allocation
Domain

Patient area
Demand
Characterization
Patient
demand

Cap. Location
/Allocation

Bin Sizing

Space
Requirements

Space
plan

Nurse’s Ward Design

Medication
Volumetrics
Storage Media

Figure 3-3: Applying the four domains of the AD methodology for a general design problem for
medication supply for patients at the hospital level [5]

30

3.3 Costs concepts
The idea of the Commonality Factor (CF) is to group the maximum number of patients (i.e.
patient 1 up to patient n where n represents the total number of patients) to receive a single
common medication. Thus, the higher the CF the more patients can receive the same
medication. The CF will be part of a procedure designed to minimize the costs associated with
the delivery process and will be measured as an independent variable.
There are three types of costs that could be measured as dependent variables to the CF:
1) Material Handling Cost (HC): The handling cost is defined as the cost of transporting the
medications over a specified distance. For example, the distance from the nurse’s station
to all of the patient areas. It will be calculated using the following formula:
𝑯𝑪 = 𝑼  𝑿  𝑴𝑪𝑫

(3.1)

where
U = cost of medication cart usage
MCD = moving cost of the medication cart per unit distance
2) Inventory Holding Cost (H) – Hs are the costs associated with storing medications at the
nurse’s station, the focused store (FS) or the medication cart (MC). Storing medications
in the MC will incur a holding cost penalty since it is not considered a storage area. The
main storage area for the medications is the nurse’s station with the FS as the secondary
storage area. Once the vendor delivers the medications to the nurse’s station, they could
be stocked and stored at the nurse’s station or transported via the MC and distributed to
the stationary FS for storage. The formula for H is:
𝟏

𝑯 =    𝟐 𝑸𝒊𝑪

(3.2)

where
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Q = how many units are purchased at a time/quantity ordered
i = interest rate
C = cost of each medication
3. Variable Facility Cost (VC) – This is the cost of moving medications over a distance.
The calculation that is used is:
VC = MMC X TFM

(3.3)

where
MMC = Medication Cart Movement Cost (refer to Parametric Analysis slide)
TFM = Total Footage Moved
Whether it is the daily or yearly costs, in order to determine the total cost of a medication
distribution system it is important to note that there are two components to this cost. There is
the: (1) total transportation costs, and, (2) medication distribution costs. It is summarized in the
formula below:
𝑻𝑴𝑫𝑪 =   𝑻. 𝑪. 𝑻. +  𝑴𝑫𝑪

(3.4)

where
TMDC = Total Medication Distribution Costs
T.C.T. = Total Transportation Costs
MDC = Medication Distribution Costs
First, there is the cost of transportation from the vendor to the hospital can be represented by:
𝑻𝑪𝑻 =   𝑪. 𝑻. +  𝑫𝑪 +   𝑯𝒐𝒍𝒅𝒊𝒏𝒈  𝑪𝒐𝒔𝒕
where
C.T. = Cost of Transportation
DC = Distance Cost from vendor warehouse to hospital
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(3.5)

Thus, the second component to the Total Medication Distribution Costs (TMDC) is the cost of
operating a medication distribution system between the nursing station and each patient can be
determined by the following formula:
𝑻𝑴𝑫𝑪   = 𝑺𝑪 + 𝑯𝒐𝒍𝒅𝒊𝒏𝒈  𝑪𝒐𝒔𝒕   𝑷𝑶𝑼 +   𝑺𝒕𝒐𝒄𝒌𝒐𝒖𝒕  𝑪𝒐𝒔𝒕𝒔 + 𝑯𝑪

(3.6)

where
SC = Setup Costs
POU = Point Of Use
HC = Material Handling Cost
For the present thesis, only the TMDC will be calculated since we are only concerned with
transportation costs of medications from the nurse’s station to the patient areas.
The setup costs will be the costs of setting up a patient room. Equation 3.6 will be part of the
analysis since the case study only goes from the nurse’s station to the patient area(s).
Figure 3-1 provides a conceptual view of the general design problem for delivering medications
to patients in a way that is compatible with an integrated supply chain strategy. All design tasks
are contained in these four domains. In setting up the medication logistical system for a hospital,
customer attributes may be the attributes desired by all patients; the FRs may be flexibility,
efficiency and controllability; the DPs could be the layouts and design of the supply chain
elements themselves as composed of physical elements; and the PVs might be the people and
material handling and so on. The successful management of hospital resources planning with
incoming medications is dependent on the knowledge of nursing management.
Assuming a network analysis, the optimization network model of a FS system is graphically
represented in Figure 3-3 [12]. It also includes the assumptions made in the model.
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It starts with a vendor source (denoted as ‘Source’), which delivers medications to the ‘Nursing
Station’, which serves as the primary storage area for the medications. For the distribution of the
medications, they will be placed in storage bins contained in MC1 and MC2 (referred to as ‘Rack
1’, ‘Rack 2’ and ‘Rack 3’):

Figure 3-4: Sample optimization network model of a Focused Storage (FS) system [12]
Utilizing these MCs, there are two options that the nurses have to deliver these medications to
the patients (shown as ‘Patient Area Demand’). The first option is for the medications to be
taken from the nursing station and delivered to the patients. The second option would be for the
medications to be moved to the focused stores (depicted as ‘Store 1’ and ‘Store 2’ in the model)
and the medications can be taken to the patients from them.
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CHAPTER IV
4.0 SENSITIVITY ANALYSIS OVER DIFFERENT PARAMETERS TO DETERMINE
LOCATION/ALLOCATION OF MEDICINE TYPES IN A SPECIFIC STORAGE
LOCATION
In the present chapter, section 4.1 sets up our case studies by providing a real world example. A
specific methodology for the medication distribution design problem is presented in (Section 4.2)
by detailing how medications will be distributed to six patients utilizing a schematic nursing
layout and describing how this distribution is affected depending on different commonality
factors scenarios. Section 4.3 continues this chapter with model formulation assumptions that
will be used in Section 4.4, which introduces the mathematical model that will be utilized for the
medication distribution case study to attempt to minimize hospital facility and inventory costs.
Next, we examine both cases, beginning with an analysis of the uncapacitated case in Section
4.5. Section 4.5.1 focuses on the portfolio effects (safety-stock reduction due to the variance
reduction in risk pooling) and facilities effects (variable costs of storage and handling). Section
4.5.2 considers the portfolio effects. Section 4.5.3 provides us with several design rules of
thumb based on analysis that is pertinent only to the uncapacitated case. Section 4.5.4 provides a
closer examination of the portfolio rule. Section 4.6 provides an analysis of the capacitated case
by describing the simulation model used to mimic capacitated conditions. The final section,
section 4.7 examines the results of the uncapacitated case (section 4.7.1) and the capacitated case
(section 4.7.2).
4.1 Case study
In City X, there are five areas hospitals that range from a 110-bed hospital to a 327-bed hospital.
Each hospital consists of a Medical/Surgical unit, Telemetry unit, Emergency Department,
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Orthopedic/Neurosurgery unit, Neonatal Intensive Care unit, and an Intensive Care Unit (ICU).
For the present thesis, focus will be placed on the ICU. The ICU is a specialized section of the
hospital that can provide comprehensive and continuous care for inpatients who are critically ill
and who can benefit from treatment [26]. A typical ICU layout is shown below:

Figure 4-1: Typical Intensive Care Unit layout
In all of the hospitals that were chosen for this study, the ICU consists of 12 beds with a normal
patient to nurse ratio of 6:1; range 4:1 to 8:1 [25]. This implies that under normal conditions one
nurse can provide up to 6 patients with a single medication (i.e. CF = 6). There are two
medication carts available that are stored in a designated area near the nurse’s station (i.e.
Medication Cart Storage Area). The medications, which are stored at the nurse’s station, are
loaded onto the medication cart and distributed either to the patients or the focused stores (shown
as a rectangle labeled ‘FS’). The three focused stores shown in the diagram are all within the
vicinity of the patient areas and serve as easy access points for medications when the nurses
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deem it necessary to obtain medications from them instead of the nurse’s station. Two nurses
(one working the 7am to 7pm shift and the other working 7pm to 7am) provide each inpatient
with their medications once every 8 hours. Thus, the sample study consists of a total of 10
nurses providing medications to a total of 120 patients up to three times per day.
4.2 Methodology
In section 3.2.2, the AD method was presented in Figure 3-3, which is very similar to the
drawing shown in Figure 4-2. Figure 3-3 provides a generalistic view of the medication
distribution system. Figure 4-2 is focused more at the storage level and will play a key role
when utilized with the CF, as explained later in this section.
Figure 4-2 [12] displays the effectiveness of commonality on optimizing a medication
distribution system. This figure breaks down the network design described in Figure 3-3 for a
commonality factor (CF) up to 3, concentrating solely on the distribution of medications to three
patient areas that each has a FS. If it is determined that CF = 1, the nurse would deliver the
particular medications that each patient needs. If CF = 2, the nurse could move the cart to FS2
and then travel a short distance and deliver the same medication type to both PA1 and PA2. In a
CF = 3 scenario, the nurses could push the cart to FS3 and deliver the particular medication type
could then be delivered to all three patient areas.
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Figure 4-2: Proposed distribution of medications from nurse’s station to patient areas [12]
4.3 Model Formulation Assumptions
The model formulation is based on the following assumptions for both uncapacitated and
capacitated cases:
•

All beds in the nurse’s ward will always be occupied with inpatients

•

One nurse can administer medications up to a maximum of six patients

•

If the patient has more than one medication type that the nurse must administer then the
nurse must provide that particular medication and go retrieve subsequent medications
(from the nurse’s station or focused store)
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•

There are a maximum of five medication types that are available

•

Safety stock is taken into consideration (non-linear constraint)

•

Needed medications for patients can always be resupplied from the nurse’s station (NS)

•

The NS has infinite storage capacity and is always readily stocked with medications (i.e.
reordering of medications is assumed and there is no medication shortage)

•

Medication carts and focused stores can satisfy more than one patient area component
demand, but only one store for patient area per component demand is allowed

•

Distance from the NS to any patient will be 200 feet and the distance from the NS to any
focused store is 220 feet

•

Common zones exist, will be located halfway between two patients and will also be
halfway (100 feet) between these two patients and the NS

•

All medication types will have a maximum stock of 60 pills and a safety stock of 20 pills
but a stock level of 40 pills will also exist

•

The bin size of the MC is normally 10 pills but if the stock level of any medication type
is 20 pills or less then the bin size of the MC is 5 pills

•

For the capacitated case only,
o A minimum 25% loss in capacity will be assumed
o Focused stores exist and will serve as storage locations

•

The interest rate i will be 14%

4.4 Mathematical Model for the Medicine Distribution System
The solution of the problem is based on a constrained nonlinear model. The objective is to
minimize a cost function that includes:
1. Facility costs, including fixed, variable, and units of medicine movement costs, and,
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2. Inventory holding cost (H) based on the average inventory level
The constraints will guarantee (1) unique allocation of medications to patient areas, (2)
identification of selected medications, (3) satisfaction of minimum space requirements to hold
medications in the focused store or the nurse’s station (NS), and (4) satisfaction of storage
capacity of the focused stores and at the NS.
The deletion of the fourth set of constraints will render the uncapacitated case.
The main variables of the model are defined as follows:
  ajkp =

1,
0,

if  focused  store  𝑗  serves  patient  𝑘  for  medication  𝑝 ∗
otherwise

* if j=0, the storage point is the source
Based on these definitions, the complete mathematical model is given as:
Minimize

∑∑∑ HC

jkp

⋅ DM jkp ⋅ a jkp

j∈F k∈C p∈P

⋅ 2!"#
⋅ a   ∙ 𝑇𝐹𝑀!"#
∑ ∑∑VC𝑀𝑀𝐶

+

j

jkp

k∈C j∈F p∈P

∑∑Val

+

p

⋅ H ⋅ (SS jp + ( 1 2 )Q jp )

j∈F p∈P

Subject to

∑a

jkp

=1

∀ k ∈ C, p ∈ P

(4.1)

j∈F

Mean jp = ∑ DM kp a jkp

∀

j ∈ F, p ∈ P

Var jp = ∑ DVkp a jkp

∀

j ∈ F, p ∈ P

SS jp = k pσ jp

∀

j ∈ F, p ∈ P

k∈C

k∈C
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(4.2a)

σ jp = Rp + Lp Varjp

∀

j ∈ F, p ∈ P

(4.2b)

Q jp ≥ ( R p + L p ) Mean jp + SS jp

∀

j ∈ F, p ∈ P

(4.2c)

∑ 2 ⋅ Vol

∀

j∈F ≠ 0

(4.3)

∀

j ∈ F , k ∈ C, p ∈ P

(4.4)

p

⋅ Q jp ≤ Cap j

p∈P

a jkp ∈ {0,1 }

The sets C, F, and P are used in the model are defined as follows:
C

= set of patient locations (i.e., use points)

F

= set of potential storage points (e.g., focused stores)

P

= set of medications j

The parameters used in the model are defined as follows:
Capj

= maximum capacity of focused store j (volume per bin)

DMkp

= demand mean for medication p at patient area k (units/day)

DVkp

= demand variance for medication p at patient area k (units2/day)

HCjkp

= handling cost to move medication p from storage point j to patient area k ($ per unit)

H

= inventory holding cost rate ($/$ per day)

kp

= safety factor for medication p (found by table lookup, based on required service level,
or probability of no stockout over a replenishment interval)

Lp

= lead time from source to storage point for medication p (days)

MMCikp = movement cost to transport medication p to patient k using medication cart i ($ per
day)
Rp

= inventory review cycle for medication p (days)

Valp

= value of medication p ($/unit)

Volp

= volume of medication p (e.g., tote size, cubic feet, etc.)
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We observe that set (4.3a) in the model does not represent "true" constraints. Instead, they
define dependent variables that are used in the development of the minimum lot size constraint
(4.3c) and the capacity constraint (4.4). These dependent variables are defined as follows:
Meanjp = demand mean of medication p at focused store j (units/day)
SSjp

= safety stock of medication p at focused store j (units)

Qjp

= order quantity of medication p at focused store j (units)

Varjp

= demand variance of medication p at focused store j (units2/day)

Equation 4.1 states that the total sum of all of the available focused stores j with medication p
available for patient k is one for all patients k contained in the nurse’s ward C and all medications
p contained in total inventory P.
The next set of equations (4.2a) all show the calculations used to determine the mean, variance
and safety stock of focused store j containing medication p. The mean is determined by
calculating the sum of the demand means of all medications p that patient k requires multiplied
by the available focused stores j containing medication p for patient k. Similarily, the demand
variance is calculated in the same manner as the demand mean where the sum of all demand
variances of medication p for patient k multiplied by the number of available focused stores. The
third set in equation 4.2a describes the calculation of the safety stock for focused store j for
medication p. The safety factor of the medication p and the standard deviation of the focused
store j for medication p (which is calculated by using equation 4.2b) must be known for it to be
calculated. Equation 4.2c shows that the order quantity of focused store j with medication p is
greater than or equal to the safety stock of focused store j for medication p combined with the
additive total of the inventory review cycle for medication p and the lead time from source to
storage point for medication p multiplied by the demand mean of medication p at focused store j.
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The set of equations in Equation 4.2a, 4.2b and 4.2c are all for all focused stores j contained in
the total number of focused stores F and all medications p contained in total inventory P.
This is followed by Equation 4.3, which shows that the maximum capacity of focused store j is
greater than or equal to the sum of twice the volume of medication p multiplied by the order
quantity of focused store j with medication p. This is for all focused stores j contained in the
total number of focused stores F being used (i.e. ≠0).
Equation 4.4 says that the available focused stores j with medication p available for patient k
must be one (i.e. used to serve patient k with medication p) or zero (otherwise). This is for all
focused stores j contained in the total number of focused stores F, for all patients k contained in
the nurse’s ward C and all medications p contained in total inventory P.
•

Material handling cost (H) – The handling cost per unit distance is identical for the CZ
and the FS. However, since the FS is located closer to the patient area, H is lower for the
FS than the CZ. Table 4-1 gives some representative costs per foot of travel distance per
unit load for the medication cart:
Table 4-1: Parametric Analysis for the base case of a single patient
Parameter

Base Case

Range

1:1

1:1 - 3:1

0

0 – 90

1

1 – 30

$2.50

$0.25 - 50

$0.0040/
$0.0049/
$0.0113
14%

---

Patient Area (PA) Share
of Demand
Lead time (days)
Review Interval (days)
Item Value
Medicine Movement Cost
(cost/foot) (NS->CZ/NS>FS/NS->PA)
Cost of Capital (Annual
rate)
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14%

•

Variable facilities cost (VC) – VC is near zero for the CZ if space is readily available in
the central stores. For the FSs, the VC depends on the storage medium. Table 4-2 gives
representative costs ($/location/day) for typical storage media used for storage of
medications:
Table 4-2: Variable Facility Costs
Storage Medium

Storage Cost ($/day)

Nursing Station

$0.02

Focused Store (FS)

$0.075

Medication Cart (MC)

$1.00

Several parameters do not differ between the focused stores and the medication cart:
1. Total patient demand
2. Variance (at patient area level)
3. Review interval
4. Lead-time interval
5. Cost of capital
6. Medication unit value
7. Medication volumetrics
4.5 Analysis of the Uncapacitated Case
The uncapacitated case involves modeling a problem without capacity constraints to quantify the
storage requirements for a mix of items and to determine an initial location/allocation
assignment. The approach will be to compare total holding costs and total material handling
costs of stocks of medications and describe the costs per patient area as functions of the
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commonality factor (CF). This method provides insights into the conditions under which the
safety stock (SS) should be pooled or dispersed. It is important to note that centralization of the
SS does not preclude focused storage of the cycle stock at the patient area level. However, if the
SS is centralized then direct point-of-use delivery from supplier to nursing station is precluded.
Based on experience with implementation of focused storage in industry, the margin of error in
the input cost data is estimated to be roughly ±15%. Thus, if the total cost of a centralized and
decentralized system is within ±15%, the decision maker is indifferent.
4.5.1 Portfolio and Facility Effects
Table 4-4 shows the two main categories of costs, inventory holding costs and facilities costs:
Table 4-3: Cost Categories
Holding Costs

Facilities Costs

Safety Stock Holding Costs

Variable Facility Costs

Cycle Stock Holding Costs

Handling Costs

However, for the medication distribution design problem, only the facilities costs (i.e. Variable
Facility Costs and Handling Costs) will be of value in conducting a cost analysis. The Safety
Stock Holding Costs and the Cycle Stock Holding Costs will not be significant variables to
account for this hospital logistics network.
Portfolio effect is the savings in inventory holding cost resulting from risk pooling (variance
reduction) when stocks are centralized and the demand is concentrated on one stock point. In the
case of commonality, there are centralization benefits from a smoothing effect of demand
variability. When the demand is below average in one patient area, the demand in another
patient area may be above average such that the variability of demand at the nurse’s station is
lower.
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The variable Var (variance of demand at the FSs or CZs) will depend on the CF (i.e. number of
patients that demand a given medication). Safety stock (SS) is defined as follows (refer to the
mathematical model in the previous chapter):

SS = k R + L Var
Let the parameter CF be the number of patient areas that demand a single medication. If each
patient area is served by its own local focused store, then the SS level is independent of CF. If
the patient areas are served by a single CZ, then the SS level (per patient area) at the CZ is
proportional to the factor:

1
CF

(4.7)

The following equation fragment shows the SS contribution to total cost and how the SS-related
cost varies with CF for a centralized system:

(VC ⋅ 2 ⋅ Vol + Val ⋅ H ⋅ )(k
3
2

R+L

1 ⎞
⎟
⎝ CF ⎠

)( Var )⎛⎜

(4.8)

where
CF = commonality factor (number of patient areas using the medication)
VC = variable facility cost (Table 4-1)
Vol = Medication volumetrics
Val = Medication unit value
H

= Inventory holding cost rate ($/$/day)

Var = Variance of demand
k = Safety factor (number of standard deviations of the normal distribution)
L = Lead-time interval from supplier
R = Review interval for periodic review of stock level
46

Note that the medication unit value, volumetrics, facility variable cost, holding cost factor, and
safety factor all affect the total cost in the same multiplicative fashion. Lead-time, review
interval and variance affect the total cost by the square root relationship as well as the number of
patient areas by the inverse square root relationship. These relationships provide insights into
the parametric analysis.
Consider the base case scenario in Table 4-1. The coefficient of variation is:
CV = (Standard Deviation of Demand) / (Mean Demand).
The CV = 0.5 in the base case was derived from a mean demand of 30 units/day and a standard
deviation of 15 units/day.
Table 4-4 shows system costs for the base case and a single patient area (i.e. CF = 1) in the
uncapacitated static model. It also summarizes the cost elements for the two extreme cases. If
the cost per patient area is plotted versus the commonality factor, the total cost of centralization
will always be higher for the case of one patient area:
Table 4-4: Absolute and Relative Costs of the FS and the CZ for CF = 1
Cost
Component

Absolute

Relative (%)

FS

CZ

FS

CZ

0.3

0.3

42.74

35.29

Handling Cost

0.402

0.55

57.26

64.71

Total

0.702

0.85

100

100

Variable
Facility Cost

It will be assumed that all of the stock will be centrally located at the nurse’s station and
delivered from this source to the FS via a MC. The nurse’s station will be replenished from the
outside supplier on a dock-to-stock basis and the stationary FS is replenished from the MC on a
Kanban pull basis.
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Table 4-5 shows that both costs are more cost effective with the utilization of the common zone
to get medications to the patients than with the focused store for the case of three patient areas
and decentralized stocks of medication. For centralized stocks, the handling costs are relatively
high and the variable facility costs are relatively low compared to decentralized medication
stocks. This difference in variable facility costs relates to the types of storage media (Table 4-1):
Table 4-5: Summary of the Absolute and Relative Costs for CF = 3
Cost
Component
Variable
Facility
Cost
Handling
Cost
Total

Absolute

Relative (%)

FS

CZ

FS

CZ

0.9

0.3

42.74

41.32

1.206

0.426

57.26

58.68

2.106

0.726

100

100

Figure 4-3 illustrates the effect of commonality on all costs. The condition of linearity was
assumed between two or more patients. Note that total costs are equal for the case of two patient
areas and that costs are all in the indifference region in the range of 1 < CF < 7:
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Figure 4-3: Base Case Cost Relationships
The parametric analysis first addresses factors that affect the total cost multiplicatively. Figure
4-4 shows that a low value item is an excellent candidate for focused store, regardless of the
commonality. In this case, the handling cost is relatively high in comparison to the variable
facility cost. Since the FS is closer to the patient area than the CZ, the FS option is less
expensive. Conversely, Figure 4-5 shows that for a high-value item, centralized stores are
preferred for any degree of commonality. Figures 4-4 and 4-5 suggest the need for further
parametric analysis over a wide range of unit values:
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Figure 4-4: Low Value Item Cost Relationships
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Figure 4-5: High Value Item Cost Relationships
Figure 4-5 plots unit value vs. the value of CF at which centralization becomes marginally
preferred (total cost curve coinciding with the lower 15% bound). For example, a unit value of
$50 the total cost curve crosses the lower 15% bound at CF = 2. The base case value of $2.50
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per unit is near the knee of the cost curve. The cost curve is relatively flat at CF of 2 to 3 for unit
values over $4. The conclusion from this relationship might be that for unit values of $4, central
storage of safety stocks is preferred for any degree of commonality (CF > 1). In other words,
items of value over $4 are not good candidates for direct point-of-use delivery to the patient area.
Instead, the safety stock should be centralized at the nurse’s station.
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Figure 4-6: Decision sensitivity to Unit Value
Charts such as Figures 4-3, 4-4, 4-5 and 4-6 reveal the domains in which focused storage is
preferred. There is a high degree of similarity for all factors that impact total cost
multiplicatively.
The following four parameters are consistent, in that low values favor focused stores and high
values favor centralized stores:
•

Unit Value

•

Coefficient of variation

•

Interest rate
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•

Service level

These figures show that the handling cost can be a sensitive parameter. Consequently, it is
important to accurately estimate the handling and transportation costs. These figures also show
that lead-time has little effect on the decision to utilize the focused stores. This effect is
explained by the fact that total cost is a function of the square root of lead-time.
4.5.2 Design Rules-of-Thumb based on analysis of the Uncapacitated Model
A primary objective of the characterization is to identify rules-of-thumb to implement
commonality analysis in design toolsets. An analysis of the uncapacitated model yields rules
related to safety stock holding cost and vendor package size.
4.5.3 Portfolio rule
This rule is intended to evaluate the potential portfolio effect as the number of using patient areas
increases. For CF=1, calculate the (1) ratio of actual safety stock holding cost with respect to the
total cost of the Common Zone (CZ), and (2) difference of total cost between common zone and
focused store with respect to the common zone total cost. If (1) is greater than (2), then there is a
significant opportunity to gain portfolio effects by centralizing stocks at commonality factors
greater or equal to 2. This result can be summarized in terms of the following rule:
Let
%SS

= Safety stock cost as percentage of total cost for a completely centralized system

TC(C) = Total cost for centralized stores
TC(F) = Total cost for focused stores
If

⎡ TC(C) - TC(F) ⎤
%SS > ⎢
⎥ *100
TC(C)
⎣
⎦

(4.9)
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This is followed by the pooling of the SSs for common medications in a centralized store. A test
of the rule shows that it provides valid results in 94% of possible cases examined, based on the
parametric ranges specified in Table 4-1. Rule failures tend to be at lower degrees of
commonality (e.g. CF ≤ 6). The errors tend to be in favor of centralized stores. Therefore, this
rule is robust in the sense that if it recommends focused stores, the user has a high degree of
confidence in adopting focused stores. Another favorable feature of the rule is that the penalty
costs of the incorrect assignments are less than 10%.
4.6 Analysis of the Capacitated Case
The purpose of the capacitated analysis is to characterize the focused storage problem of location
and allocation for a mix of medications in a multi-echelon inventory system under storage
constraints. A mixed integer-programming model is used to analyze the multi-medication case.
The modeling toolset for this research was the Arena™ Simulation Program (Version 14.0) and
Microsoft Excel™ running on an Intel Core i7/596 MB laptop computer with 4GB of memory.
The first step was to model a problem without capacity constraints to quantify the storage
requirements for a mix of medications and to determine an initial location/allocation assignment.
The basic approach for the capacitated analysis was to find the uncapacitated solution that we
obtain from the simulation results. This provided a reliable baseline of data from which further
studies could be based off of.
In the determination an effective medication distribution system, Table 4-6 shows the medication
information for the different case scenarios analyzed for the sensitivity analysis:
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Table 4-6: Medication Costs
Medication
P1

Item Value
($/unit)
2.50

P2

48.50

P3

5.40

P4

21.15

P5

10.45

There were six models that were developed to mimic each of the six different commonality
scenarios: CF = 1, CF =2, CF =3, CF = 4, CF = 5 and CF = 6. Nonetheless, each program
followed a similar path as shown in Figure 4-7 (uncapacitated) and Figure 4-8 (capacitated). In
each program, the assigned entity (i.e. for the simulation program is the medications) went
through the first part of the simulation, which was the nurse’s station, which is the primary
storage point for all of the medications:

Figure 4-7: Schematic of the simulation model for the Uncapacitated Case
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Figure 4-8: Schematic of the simulation model for the Capacitated Case
The entity then entered the next part of the program, the inventory component, in which the
demand is created by the simulation model for each particular medication was tallied and
compared against the available medication inventory to ensure there is adequate stock. If there
is enough stock available of the needed medication(s) for the nurse to deliver them to the
patient(s), then the bin size of the medication cart is 10, which means up to 10 medication pills of
any type can be delivered to the patients at a time. However, when a predetermined safety stock
is reached, the needed medications are merely retrieved from the nursing station, thus with no
lead-time required. In this situation, the bin size is 5 (i.e. 5 pills of any type can be delivered to
the patient(s) at a time). Additionally, a record was kept of how many times per day the bin size
of 5 and the bin size of 10 was used. Once the medications were restocked (at the focused stores
and/or patient areas) the inventory was adjusted to reflect the updated inventory level. The unit
cost for each type of medication was taken into account. This logic was utilized in the six
scenarios developed using the Arena program (Figures 4-11, 4-12 and 4-13 are screenshots from
the Arena program for CF = 1, CF = 2 and CF = 3).
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Minimum and maximum inventory levels were established to determine when restocking of the
appropriate medication types should take place for each commonality factor, as shown in Tables
4-7 and 4-8 for the cases up to a Commonality Factor (CF) of 3:
Table 4-7: Maximum and minimum inventory of the corresponding medication type for the
CF = 1 and CF = 3 scenario
Medication Type
P1

Maximum Inventory
(pills/box)
60

Minimum Inventory
(pills/box)
20

P2

40

20

P3

40

20

P4

60

20

P5

60

20

Table 4-8: Patient pairings with maximum and minimum inventory for each medication type for
the CF = 2 scenario
Medication Type with Maximum and Minimum Inventory (pills/box)
Patient Pairing

1

2

3

4

5

PA1-PA2

0

40/20

0

60/20

0

PA2-PA3

0

0

40/20

0

60/20

PA1-PA3

60/20

0

0

0

0

Finally, the entity arrived at the end component of the simulation, where a sequence simulating
the distribution of the medications from the nurse’s station to the medication carts (MCs) and
eventually making its way to the patient areas or the focused stores via the MCs or was created.
The common zone (depicted as a oval that is near the patient areas in Figures 4-8 and 4-9) is not
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an actual physical location but an area designated by the nurses to temporarily store medications
should the situation arise to ensure the patients are provided their medications in a timely but
cost effective basis. Referring to Figure 4-8, this movement by the nurses is denoted by the light
dashed arrow

. Both the material handling costs and the inventory holding costs for each

medication type were tabulated.
The simulations were each replicated once over 365 days to obtain reliable results.
The next step was to systematically impose binding constraints by reducing the storage
capacities of the common zones and/or the medication cart(s), thereby limiting the medications
that can be provided to the patient areas, until a stock point below the capacity required by a
solution was reached. This placed more of a focus on the focused stores to provide the needed
medications to the patients to prevent a shortage of medications. For a given iteration,
alternatives for an affected medication type are forced into the model to determine the costs of
these alternatives. These costs were compared and examined to demonstrate the model validity.
The forced solution method was applied to validate the solutions obtained from the storage
constrained optimization model.
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Figure 4-9: Schematic of Uncapacitated Case
4.7 Analysis of the Results
4.7.1 Uncapacitated Case
Figure 4-9 demonstrates a scenario indicative of a possible solution result of the simulation
model for the uncapacitated case for the case of three patients.
The nursing station, referred to as the ‘Source’, is the starting point. The nurse’s station is the
primary storage area for the medications and serves as the pickup point where the medications
are loaded onto the medication cart and the appropriate medications are delivered to each patient
common area (i.e. PA1, PA2 and PA3). If any of the medication types must be reordered, then
the lead-time is greater than 0. The medication types are referred to as P1, P2, P3, P4 and P5.
Medication types P2, P4 and P5 are distributed to the common areas of all three patients by the
medication cart with P2 is being supplied to the common areas of PA1 and PA2, P4 going to the
common areas of PA2 and PA3 and only P5 going to the common area of PA3.
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We also note that from the focused store (FS) 1, the patient in PA1 is receiving medication types
P1, P3 and P5. From FS2, the patient in PA2 is receiving also P1, P3 and P5. Finally, from FS3,
we see that the patient in PA3 is getting P1 and P3.
In this scenario, Level I is indicative of the lowest level in the multi-echelon system. This is
where the nurse is providing each patient with medications from the medication cabinet near
each patient or from the nurse’s station. Level II is the next tier in the multi-echelon level, which
would involve all of the patients being provided medications by the nurses from either or both
the medication cabinets and the nurse’s station.

Figure 4-10: Schematic of Capacitated Case
4.7.2 Capacitated Case
Binding constraints were systematically imposed by reducing the storage capacities of the
common zones and/or the medication cart(s), thereby limiting the medications that can be
provided to the patient areas, until a stock point below the capacity required by a solution was
reached. This affects the ability of the nurses to provide the needed medications to the patients
on a timely basis. Referring to Figure 4-10, medication types P1, P3 and P5 are still supplying
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the common areas for the case of three patients but the similarities end there. FS1 can only
provide medication types P1 and P3 to the common area of PA1. FS13 must resupply FS1 with
medication type P5. What is also telling is that PA2 is only getting the medication types P3 and
P5 from FS2 and medication type P3 is only being provided to the common area of PA3. To
compensate, FS23 displays a portfolio effect by supplying medication type P1 to the FS2 and
FS3 so that this medication can be given to the common areas of PA2 and PA3.
In this scenario, Level I is the lowest level of the multi-echelon system where the each of the
focused stores is providing medications (i.e. by the nurse) to each patient. Level II is the next
tier in the multi-echelon level, which would involve all of the patients being provided
medications by the nurses from either/both of the focused stores and the nurse’s station.
4.7.3 Comparison with computational results from Arena simulation run
Figures 4-11, 4-12 and 4-13 show screenshots of the simulation models that were developed and
run using the Arena program for the following Commonality Factor (CF) scenarios: CF = 1, CF
= 2 and CF =3. Note that models were also run for a CF scenario of 4, 5 and 6:

Figure 4-11: Arena simulation model for CF = 1 scenario
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Figure 4-12: Arena simulation model for CF = 2 scenario

Figure 4-13: Arena simulation model for CF = 3 scenario
Table 4-9 displays the results of the Variable Facility Costs (VC), Material Handling Costs (HC),
the inventory holding cost (H) and the bin sizes of 5 and 10 for Patient 1, Medication Type 1
only, for the six commonality factor scenarios. A steady increase in HC is evident as the
commonality increases. This is consistent with the idea that as the number of patients receiving
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the same medication increases the HC will reflect a corresponding increase in cost. The results
of all six simulations also showed that H remained steady at $7 for all of the commonality
scenarios. Where the savings for the hospitals is most apparent is in the VC. There is a cost
savings of 4.5% from CF = 1 to CF = 2 (i.e. $326.06 to $297.99). There is a dramatic jump from
CF = 2 to CF = 3 where a 29.1% reduction occurs (i.e. $297.99 to $163.57). From CF = 3 to CF
= 4 there is an 18.7% drop but the savings is less pronounced from CF = 4 to CF = 5 (8.4%) and
from CF = 5 to CF = 6 (9.1%). The cost savings are evident as the transportation of the
medications transitions from the nurse’s station to the patient area (CF = 1) to focused store (CF
= 2) and then to the common area (CF = 3) as the commonality of single medications among
patients increases. These results also lend support to Figure 4-3, which shows the steady line for
H and the increasing HC as the commonality increases. The steepness of the curve is
pronounced as you go from CF =1 to CF = 2 and then increases from CF = 2 to CF = 3. After
CF = 3 the curve is not as steep.
Finally, the bin sizes among the different commonality factors seem to indicate a general trend of
the commonality increasing as the use of the bin sizes 5 and 10 both decrease. As the CF
increases, the decreasing use of bin size 5 is a good indicator of the reduced need to restock
medications. Moreover, the use of bin size 10 decreasing seems to indicate there is less
frequency of trips that the nurses must take to administer the medications as the commonality
increases. There is a dramatic decrease from CF = 1 to CF = 2 in the bin size of 10 and another
CF = 2 to CF = 3 but not as steep. Once you reach CF = 4, the bin size levels off for both cases.
A similar pattern is shown in the bin size of 5 as the bin size of 10 but not as pronounced:
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Table 4-9: Comparisons between several variables from Arena simulation run for the
Commonality Factors 1, 2, 3, 4, 5 and 6 for Patient 1, Medication Type 1

Commonality
Factor

1
2
3
4
5
6

Medicine
Movement
Costs
(MMC)
($/day)
326.06
297.99
163.57
111.96
94.59
78.89

Inventory
Holding
Costs
(H)
($/day)

Material
Handling
Costs (HC)
($/day)

7
7
7
7
7
7

177.24
322.37
533.93
679.56
864.42
985.84
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Total
Medication
Distribution
Costs
(TMDC)
($/day)
383.06
354.99
220.57
168.96
151.59
135.89

Bin Sizes
(per day)

5
10
1.68 26.69
0.85 14.10
0.77 8.83
0.18 1.10
0.16 1.10
0.13 1.10

CHAPTER V
5.0 CONCLUSIONS AND RECOMMENDATIONS
The major contribution of the present work is the application of the Axiomatic Design
methodology to the medication distribution design case study, which provides nurses with the
ability to deliver medications to inpatients on a cost-effective basis.
The main problem considered in the present study was reduced into hierarchical, lower-level
problems to assist in identifying the potential underlying issues that may arise when searching
for a solution to the primary issue. This was accomplished by decomposing the primary issue for
the focused store case study in terms of functional requirement with the corresponding decision
parameter. This was then decomposed into basic, lower-level FRs and DPs. Constraints were
placed in this study to maintain appropriate bounds on the accepted solution.
The next step of the AD process would be to identify the process variables for the decision
parameters, ensure the original need for this project was satisfied and finally to evaluate the
information content that is collected from observations of the results.
The focused store methodology was introduced and was an integral part of the development of
the mathematical model for this case study. It is hoped that the analysis of this model will
provide nursing managers with a results-oriented approach to give them options for an effective
medical distribution system in their never-ending endeavor towards providing quality patient
care.
Another significant development that the analysis of the mathematical model revealed was the
development of both the capacitated and the uncapacitated case. The following observations
were noted for the uncapacitated case:
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1. The portfolio effect increases proportionally to

1
CF

2. For unit values greater than $4 and more than two patient areas, it would be necessary to
centralize the SS
3. For unit values of less than $4 and typical cost structures, commonality may be neglected
up to CF > 7
4. For low interest rate (<14% per year) and low coefficient of variation (<0.5), focused
stores are preferred for any value of CF < 13
5. In all of the uncapacitated scenarios, there was a noted indifference that was typically
seen for the CFs that were between 3 to 6
6. The portfolio rule performed very well and should be very useful to practitioners in
designing focused stores. The rules tend to favor centralization and are thus
conservative. On the other hand, the rules tend to side towards decentralization in cases
where the penalty costs of an incorrect decision are small
As far as the analysis for the capacitated case, it suggested these general observations:
1. The portfolio effect on the material handling cost is the major factor for deciding location
and allocation
2. Binding capacity at one location has modest effect on total cost but can have substantial
effects on location/allocation decisions
3. The material handling cost is the major decision factor when portfolio effect benefits are
diminished due to binding storage capacities
4. The capacity constraints tended to increase the handling costs
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It is recommended that this research be extended to cover other areas in the study of medical
distribution design systems including: (1) the development of multi-period models, and, (2) the
incorporation of more complex simulation tools.
Finally, it is hoped that the AD methodology will become a viable option that companies should
consider when developing new products or improving on the ones they already have.
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GLOSSARY
Axiomatic Design - a process that focuses on the generation of functional requirements and the
selection of functional requirements to meet the customer needs for product and/or process
design.
Axioms - truths that cannot be derived but for which there are no counterexamples or exceptions.
Capacitated - when there are limitations as to the capacity or space that can store medications for
the patients. This is mainly due to the lack of resources that are available to stock the products.
Commonality Factor – number of patient areas that demand a single product.
Constraints - the bounds on acceptable solutions.
Decision Parameters - the key physical variables in the physical domain that characterizes the
design that satisfies the specified functional requirements.
Functional Requirements - the minimum set of independent requirements that completely
characterize the functional needs.
Independence Axiom - To satisfy the conditions of this axiom, the independence of FRs must
always be maintained. It also implies that when there are several FRs, the design must be such
that the FR can be satisfied without affecting any of the other as FRs [2]. The second axiom is
known as the Information Axiom, which states that among those designs that satisfy the
Independence Axiom, the design with the highest probability of functional success will be the
best design [2, 5, 6, 7].
Input constraints – constraints that are specific to the overall design goals (i.e. all designs that are
proposed must satisfy these goals).
Portfolio effect - the savings in inventory holding cost resulting from risk pooling (variance
reduction) when stocks are centralized and the demand is concentrated on one stock point.
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Process Variables - the key variables in the process domain, which characterizes the process that
can generate the specified decision parameters.
Solution-neutral environment - This means that the functional requirements must be defined
without ever thinking about something that has already been designed or what the design
solution should be.
Stock out costs - Economic consequences of not being able to meet an internal or external
demand from the current inventory. Such costs consist of internal costs (delays, labor time
wastage, lost production, etc.) and external costs (loss of profit from lost sales, and loss of future
profit due to loss of goodwill). Also called shortages costs.
System constraints – constraints that are specific to a given design; they are the result of design
decisions made.
Uncapacitated case – where one can assume that the storage space/design (i.e. focused stores) are
sufficiently large enough to accommodate any amount of inventory
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